Evidence map›Paper›PMID 32503088›Full record

SynthesisEuropean journal of neurology2020

A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.

M Romoli, I Jelcic, R Bernard-Valnet, D García Azorín, L Mancinelli, T Akhvlediani, S Monaco, P Taba, J Sellner, Infectious Disease Panel of the European Academy of Neurology

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in European journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 10 pooled it
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 10 syntheses or guidelines pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models.International journal of stroke : official journal of the International Stroke Society · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Stroke in COVID-19: A systematic review and meta-analysis.International journal of stroke : official journal of the International Stroke Society · 2021
    Pooled it
  10. Pooled it
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 8 countries.

M RomoliNeurology Unit, Maurizio Bufalini Hospital, Cesena, Italy.
I JelcicNeuroimmunology and Multiple Sclerosis Research Section, Department of Neurology, University Hospital of Zurich, Zurich, Switzerland.
R Bernard-ValnetDepartment of Clinical Neurosciences, Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois) and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-7447-344X
D García AzorínDepartment of Neurology, Hospital Clinico de Valladolid, Valladolid, Spain.ORCID 0000-0002-3132-1064
L MancinelliNeurology Unit, Maurizio Bufalini Hospital, Cesena, Italy.
T AkhvledianiAmerican MD Program, Faculty of Medicine, Tbilisi State Medical University, Tblisi, Georgia.
S MonacoDepartment of Neuroscience, Biomedicine and Movement Sciences, University Hospital of Verona, Verona, Italy.
P TabaDepartment of Neurology and Neurosurgery, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.ORCID 0000-0002-5439-1022
J SellnerDepartment of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria.ORCID 0000-0001-8749-5533
Infectious Disease Panel of the European Academy of Neurology
Hospital Clínico Universitario de Valladolid · ESOspedale “M. Bufalini” di Cesena · ITParacelsus Medical University · ATTartu University Hospital · EETbilisi State Medical University · GEUniversity Hospital of Lausanne · CHUniversity Hospital of Zurich · CHUniversity of Perugia · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeWe systematically reviewed available evidence for reports of neurological signs and symptoms in patients with COVID-19 to identify cases with severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection or immune-mediated reaction in the nervous system.

methodsWe followed PRISMA guidelines and used the MEDLINE, EMBASE, Google Scholar, MedRxiv and ChinaXiv databases to search for articles on COVID-19 and nervous system involvement that were published from 1 January to 24 April 2020. Data on design, sample size, neurological assessment and related work-up were extracted. Biases were assessed with the Newcastle-Ottawa scale.

resultsWe analysed 27 publications on potential neuroinvasive or parainfectious neurological complications of COVID-19. The reports focused on smell and taste (n = 5) and evaluation of neurological symptoms and signs in cohorts (n = 5). There were cases of Guillain-Barré syndrome/Miller-Fisher syndrome/cranial neuropathy (seven cases), meningitis/encephalitis (nine cases) and various other conditions (five cases). The number of patients with examination of cerebrospinal fluid and, in particular, SARS-CoV-2 polymerase chain reaction was negligible. Two had a positive SARS-CoV-2 polymerase chain reaction examination of cerebrospinal fluid specimen. Study of potential parenchymal involvement with magnetic resonance imaging was rare. Only four reports received a rating of the highest quality standards.

conclusionsThis systematic review failed to establish comprehensive insights into nervous system manifestations of COVID-19 beyond immune-mediated complications in the aftermath of respiratory symptoms. The authors therefore provide guidance for more careful clinical, diagnostic and epidemiological studies to characterize the manifestations and burden of neurological disease caused by SARS-CoV-2 on behalf of the Infectious Disease Panel of the European Academy of Neurology.

Indexed as

COVID-19HumansMagnetic Resonance ImagingNervous System Diseasescerebrospinal fluidCOVID-19encephalitisneuroinvasionneurological complicationsSARS-CoV-2

Identifiers

PMID32503088
PMCPMC7300895
OpenAlexW3033669663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.